InvestorsHub Logo
icon url

Toxic Avenger

01/30/11 6:59 PM

#55823 RE: roberto1 #55821

I made some money in JSDA myself, but you stated they hadn't made a dime, which was incorrect. They have actually been improving their performance since the 2007 decline, unlike DKAM.

As far as their financials, JSDA's are far superior to DKAM. And not understanding basic accounting is not an excuse for poor investing, I'm afraid.
icon url

Drugdoctor

01/30/11 7:18 PM

#55824 RE: roberto1 #55821

You nailed it roberto1 - Coast to coast distribution of products, and 2 of them, Rheingold and Olifant, may become blockbuster sellers. This is the reason that DKAM at .005 is a joke... Only technical selling and shorting has taken it there, and a good old fashioned short squeeze and value buying can take it back up.